:: Library Catalog

Imagen de Portada

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Lenguaje:
Publicado:	Zenodo 2025
Acceso en línea:	https://doi.org/10.5281/zenodo.17447586
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

NLR family genes influence homeobox transcription factor expression.
por: Mamoor, Shahan
Publicado: (2025)

Control of TOX transcription factors by the Hippo signaling pathway.
por: Mamoor, Shahan
Publicado: (2025)

An expression screen to identify genes important for trastuzumab resistance: Ccl19.
por: Mamoor, Shahan
Publicado: (2026)

An expression screen to identify genes important for trastuzumab resistance: Meox2.
por: Mamoor, Shahan
Publicado: (2026)

An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
por: Mamoor, Shahan
Publicado: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
por: Mamoor, Shahan
Publicado: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
por: Mamoor, Shahan
Publicado: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
por: Mamoor, Shahan
Publicado: (2025)

Genes expressed in the CD4 + T lymphocyte.
por: Mamoor, Shahan
Publicado: (2025)

Rip kinase expression during early development in humans.
por: Mamoor, Shahan
Publicado: (2026)

Ribosomal activation in TNBC resistance in vitro.
por: Mamoor, Shahan
Publicado: (2025)

ABCA12 functions in multi-drug resistance in human cancer.
por: Mamoor, Shahan
Publicado: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
por: Mamoor, Shahan
Publicado: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
por: Mamoor, Shahan
Publicado: (2025)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
por: Mamoor, Shahan
Publicado: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
por: Mamoor, Shahan
Publicado: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
por: Mamoor, Shahan
Publicado: (2025)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
por: Mamoor, Shahan
Publicado: (2025)

Nuclear factors that govern endotoxin tolerance in the myeloid lineage.
por: Mamoor, Shahan
Publicado: (2025)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
por: Mamoor, Shahan
Publicado: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
por: Mamoor, Shahan
Publicado: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
por: Mamoor, Shahan
Publicado: (2025)

Importin 8 is activated in childhood brain cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
por: Mamoor, Shahan
Publicado: (2025)

Telomerase control of Xist through Trf2.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
por: Mamoor, Shahan
Publicado: (2025)

HSC, CMP and CLP in mice.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
por: Mamoor, Shahan
Publicado: (2025)

Aire is a component gene of the Th17 gene signature.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
por: Mamoor, Shahan
Publicado: (2025)